Pan Tong
Pan Tong
Department of Bioinformatics and Computational Biology, UT MD Anderson Cancer Center
Verified email at
Cited by
Cited by
Comprehensive and integrative genomic characterization of hepatocellular carcinoma
A Ally, M Balasundaram, R Carlsen, E Chuah, A Clarke, N Dhalla, RA Holt, ...
Cell 169 (7), 1327-1341. e23, 2017
A pan-cancer proteomic perspective on The Cancer Genome Atlas
R Akbani, PKS Ng, HMJ Werner, M Shahmoradgoli, F Zhang, Z Ju, W Liu, ...
Nature communications 5 (1), 1-15, 2014
Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities
F Skoulidis, LA Byers, L Diao, VA Papadimitrakopoulou, P Tong, J Izzo, ...
Cancer discovery 5 (8), 860-877, 2015
STK11/LKB1 mutations and PD-1 inhibitor resistance in KRAS-mutant lung adenocarcinoma
F Skoulidis, ME Goldberg, DM Greenawalt, MD Hellmann, MM Awad, ...
Cancer discovery 8 (7), 822-835, 2018
Comprehensive and integrated genomic characterization of adult soft tissue sarcomas
AJ Lazar, MD McLellan, MH Bailey, CA Miller, EL Appelbaum, MG Cordes, ...
Cell 171 (4), 950-965, 2017
A patient-derived, pan-cancer EMT signature identifies global molecular alterations and immune target enrichment following epithelial-to-mesenchymal transition
MP Mak, P Tong, L Diao, RJ Cardnell, DL Gibbons, WN William, ...
Clinical Cancer Research 22 (3), 609-620, 2016
MOABS: model based analysis of bisulfite sequencing data
D Sun, Y Xi, B Rodriguez, HJ Park, P Tong, M Meong, MA Goodell, W Li
Genome biology 15 (2), 1-12, 2014
CD38-mediated immunosuppression as a mechanism of tumor cell escape from PD-1/PD-L1 blockade
L Chen, L Diao, Y Yang, X Yi, BL Rodriguez, Y Li, PA Villalobos, ...
Cancer discovery 8 (9), 1156-1175, 2018
The miR-200 family and the miR-183~ 96~ 182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers
ST Kundu, LA Byers, DH Peng, JD Roybal, L Diao, J Wang, P Tong, ...
Oncogene 35 (2), 173-186, 2016
ZEB1 induces LOXL2-mediated collagen stabilization and deposition in the extracellular matrix to drive lung cancer invasion and metastasis
DH Peng, C Ungewiss, P Tong, LA Byers, J Wang, JR Canales, ...
Oncogene 36 (14), 1925-1938, 2017
High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma
TH Ho, IY Park, H Zhao, P Tong, MD Champion, H Yan, FA Monzon, ...
Oncogene 35 (12), 1565-1574, 2016
Activation of the PI3K/mTOR pathway following PARP inhibition in small cell lung cancer
RJ Cardnell, Y Feng, S Mukherjee, L Diao, P Tong, CA Stewart, ...
PloS one 11 (4), e0152584, 2016
AXL inhibition suppresses the DNA damage response and sensitizes cells to PARP inhibition in multiple cancers
K Balaji, S Vijayaraghavan, L Diao, P Tong, Y Fan, JPW Carey, TN Bui, ...
Molecular Cancer Research 15 (1), 45-58, 2017
Genome-wide analysis of core promoter structures in Schizosaccharomyces pombe with DeepCAGE
H Li, J Hou, L Bai, C Hu, P Tong, Y Kang, X Zhao, Z Shao
RNA biology 12 (5), 525-537, 2015
Epithelial–Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor–Mediated Apoptosis in Non–Small Cell Lung Cancer
R Ferrarotto, R Goonatilake, SY Yoo, P Tong, U Giri, S Peng, J Minna, ...
Clinical Cancer Research 22 (7), 1674-1686, 2016
An integrated molecular analysis of lung adenocarcinomas identifies potential therapeutic targets among TTF1-negative tumors, including DNA repair proteins and Nrf2
RJG Cardnell, C Behrens, L Diao, YH Fan, X Tang, P Tong, JD Minna, ...
Clinical Cancer Research 21 (15), 3480-3491, 2015
Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death
TH Ho, P Kapur, RW Joseph, DJ Serie, JE Eckel-Passow, P Tong, J Wang, ...
Modern Pathology 29 (1), 34-42, 2016
SIBER: systematic identification of bimodally expressed genes using RNAseq data
P Tong, Y Chen, X Su, KR Coombes
Bioinformatics 29 (5), 605-613, 2013
Next-generation CDK2/9 inhibitors and anaphase catastrophe in lung cancer
M Kawakami, LM Mustachio, J Rodriguez-Canales, B Mino, J Roszik, ...
JNCI: Journal of the National Cancer Institute 109 (6), 2017
drexplorer: A tool to explore dose–response relationships and drug–drug interactions
P Tong, KR Coombes, FM Johnson, LA Byers, L Diao, DD Liu, JJ Lee, ...
Bioinformatics 31 (10), 1692-1694, 2015
The system can't perform the operation now. Try again later.
Articles 1–20